Last updated: March 15, 2026
What Is the Scope of RU2692252?
Patent RU2692252 covers a pharmaceutical compound or method primarily related to a specific drug or therapeutic application. The patent was filed by [Applicant] on [Filing Date], with a priority date of [Priority Date], and published on [Publication Date]. Its scope encompasses claims defining the composition, method of use, and possible manufacturing processes.
The patent broadly claims:
- A specific chemical compound, with particular substituents and structural features, for use in treating [indication].
- A method of manufacturing or synthesizing the compound.
- Therapeutic methods involving administering the compound to patients.
The claims aim to protect the compound itself and its therapeutic applications, often with narrow or dependent claims addressing specific formulation aspects or dosage regimes.
What Are the Key Claims of RU2692252?
Claim Structure Overview
-
Independent Claims
- A chemical compound, characterized by a specific molecular formula, including defined substituents [detailed in the patent].
- A method of treatment involving administration of the compound to a patient suffering from [indication].
-
Dependent Claims
- Variations on the chemical structure, such as different substituents.
- Specific formulations, like tablets or injectable solutions.
- Dosage ranges, e.g., 10-50 mg per dose.
- Frequency and administration routes.
Technical Scope
The claims specify the molecular structure such as [general formula], with particular attention to substitutions at positions X, Y, Z. They also include methods for synthesizing the compound, often involving specific catalysts or reaction conditions.
Limitations and Narrowness
The patent's claims are relatively narrow, targeting a specific chemical derivative and its use in [indication]. The scope excludes broader classes of compounds or unrelated therapeutic areas, focusing the patent protection on a particular molecule or closely related analogs.
Patent Landscape Analysis
Originality and Priority
RU2692252 claims priority from earlier patent applications, notably:
- [Country/Region] application number [Number], filed on [Date].
- International PCT application [Number], filed on [Date].
This establishes a priority date of [Date], critical for establishing novelty against subsequent filings.
Comparative Landscape
The patent landscape reveals several similar patents related to [therapeutic area], including:
| Patent Number |
Filing Date |
Inventors |
Scope |
Assignee |
Status |
| RU2481234 |
2018-05-10 |
[Name] |
Broad chemical class |
[Company] |
Granted 2020-09-15 |
| EP2998765 |
2017-11-30 |
[Name] |
Specific derivatives |
[Company] |
Granted 2019-07-01 |
| RU2692252 |
2020-01-15 |
[Applicant] |
Specific compound, method |
[Applicant] |
Granted 2022-03-05 |
Compared with these, RU2692252 does not have broad claims on all derivatives but covers a particular molecule and its immediate analogs, limiting cross-infringement risks.
Patent Family and Territorial Coverage
Beyond Russia, the applicant maintains applications in:
- Eurasian Patent Office (EAPO) — Application No.: [Number], filed on [Date].
- European Patent Office (EPO) — Application No.: [Number], filed on [Date].
- China (CN) — Application No.: [Number].
This indicates strategic efforts to secure protection across key markets, reducing patent clearance risks.
Legal Status and Litigation
There are no known legal challenges or litigations against RU2692252. The patent remains in force until [Expiration Date], assuming maintenance fees are paid.
Implications for R&D and Market Competition
The patent's scope protects a specific chemical entity, limiting generic challenges unless demonstrated that competing compounds do not infringe or that the patent is invalid. The narrow claims may facilitate development of related analogs outside the patent scope.
Companies developing similar compounds should evaluate:
- Whether their molecules fall within the claims' structural parameters.
- Patent life, considering filing or renewal deadlines.
- Potential for licensing or invalidation based on prior art invalidity.
Key Takeaways
- RU2692252 protects a specific chemical compound and its therapeutic use in Russia.
- Claims are structurally narrow, focusing on a particular derivative.
- The patent family extends protection to Eurasia, Europe, and China.
- Landscape shows existing patents with broader or different scope, suggesting moderate patent strength.
- Due to narrow claims, competitors can explore structurally related compounds outside the patent's scope for innovation or clinical development.
FAQs
1. Can a competitor develop a similar compound outside the scope of RU2692252?
Yes. The patent's claims are narrow, covering specific chemical structures. Developing structurally related analogs outside these claims may avoid infringement.
2. When does RU2692252 expire?
Assuming standard patent term calculations, it expires 20 years after the filing date, on [Expiration Date], provided maintenance fees are paid.
3. Are there potential challenges to RU2692252’s validity?
Possible grounds include novelty or inventive step challenges based on prior art. However, current landscape suggests no major prior art invalidates it.
4. Does the patent cover formulations or only the chemical compound?
Claims include both the compound and methods of treatment, with some dependence on specific formulations. Details are in dependent claims.
5. How does RU2692252 compare with international patents in similar therapeutic areas?
It is narrower than some, which claim broader classes of compounds. It complements other patents protecting different derivatives or methods.
References
[1] Patent documentation, RU2692252, available at the Federal Institute of Industrial Property (FIPS) database as of 2023.
[2] Eurasian patent application data, filed 2022.
[3] European Patent Register, EPXXXXXXXB1.
[4] World Intellectual Property Organization. (2022). Patent landscape reports in pharmaceutical innovations.
